Progressive supranuclear palsy | Spain| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Progressive Supranuclear Palsy

  • Progressive supranuclear palsy
    The primary aim of the present study was to determine the point prevalence of PSP in the UK. In an effort to overcome several of the methodological difficulties described above, we used the NINDS-SPSP diagnostic criteria uniformly across three surveys undertaken at national, regional and community levels. This novel approach was used both to obtain a valid prevalence figure and to estimate the degree of, and reasons for, case under-ascertainment in larger population denominators.
  • Progressive supranuclear palsy

    Therapeutic aspects

    There is right now no compelling treatment for PSP, despite the fact that researchers are hunting down better approaches to deal with the infection. PSP manifestations typically don't react to prescriptions. Medications recommended to treat Parkinson's sickness, for example, ropinirole, once in a while give extra advantage.

Speaker PPTs

High Impact List of Articles

Conference Proceedings